Net Cash Provided by (Used in) Financing Activities in USD of Inhibrx, Inc. from 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Inhibrx, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2019 to Q1 2024.
  • Inhibrx, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $38,728,000, a 10779% increase year-over-year.
  • Inhibrx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $201,961,000, a 22% decline from 2022.
  • Inhibrx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $258,551,000, a 209% increase from 2021.
  • Inhibrx, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $83,769,000, a 50% decline from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Inhibrx, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $38,728,000 +$38,372,000 +10779% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q1 2023 $356,000 -$38,868,000 -99% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $39,224,000 +$38,236,000 +3870% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $988,000 +$4,621,000 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $3,633,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Inhibrx, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $201,961,000 -$56,590,000 -22% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
2022 $258,551,000 +$174,782,000 +209% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $83,769,000 -$82,687,000 -50% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $166,456,000 +$123,130,000 +284% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $43,326,000 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.